The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Value Is Anticipated For The Genomic Cancer Panel And Profiling Market Over The Period 2026–2030?
The genomic cancer panel and profiling market has experienced substantial growth in recent years. This market is expected to expand from $10.28 billion in 2025 to $11.17 billion by 2026, achieving a compound annual growth rate (CAGR) of 8.7%. Historically, this growth has been fueled by factors such as the rising incidence of cancer, advancements in sequencing technologies, the broader availability of oncology diagnostics, increased financial support for genomic research, and the growing integration of precision medicine.
The genomic cancer panel and profiling market is anticipated to experience robust expansion over the coming years. This market is projected to reach $15.45 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.4%. Factors contributing to this growth during the forecast period include the broadening of companion diagnostics, increased uptake of liquid biopsy, the incorporation of AI into genomic analysis, a rise in oncology screening initiatives, and the creation of economical sequencing platforms. Key trends for the forecast duration encompass the growing acceptance of multi-gene cancer panels, an uptick in the utilization of next-generation sequencing, the widening application of liquid biopsy testing, an escalating need for personalized oncology solutions, and the incorporation of genomic data into clinical decision-making processes.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24225&type=smp
What Drivers Are Expected To Influence The Genomic Cancer Panel And Profiling Market During The Forecast Period?
The genomic cancer panel and profiling market is anticipated to expand significantly due to the increasing incidence of cancer. Cancer is fundamentally a disease marked by the uncontrolled multiplication and spread of abnormal cells within the body. This surge in cancer cases is attributable to an aging global population, where extended life expectancies naturally heighten the probability of developing the disease. Genomic cancer panels and profiling are instrumental in oncology care, as they enable the identification of genetic mutations and biomarkers, thereby facilitating personalized treatment strategies and improving both early detection and continuous monitoring. For instance, in January 2024, information from the American Cancer Society, a U.S.-based nonprofit, revealed that approximately 20 million new cancer cases were reported worldwide in 2022, resulting in 9.7 million deaths. Primarily driven by population growth, the global cancer burden is projected to climb to 35 million cases by 2050. Consequently, the rising number of cancer cases will fuel the growth of the genomic cancer panel and profiling market.
How Is The Genomic Cancer Panel And Profiling Market Divided Into Its Major Segments?
The genomic cancer panel and profiling market covered in this report is segmented –
1) By Tissue Testing: Solid Tissue Testing, Liquid Tissue Testing
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Other Technologies
3) By Cancer Panel Type: Single-Gene Panel, Multi-Gene Panel
4) By Application: Clinical, Research
5) By End User: Hospitals, Research And Academic Institutes, Clinical And Diagnostic Laboratories, Other End Users
Subsegments:
1) By Solid Tissue Testing: Biopsy Samples, Surgical Resection Samples, Formalin-Fixed Paraffin-Embedded (FFPE) Tissues, Fresh Frozen Tissues
2) By Liquid Tissue Testing: Blood, Urine, Saliva, Cerebrospinal Fluid (CSF), Other Bodily Fluids
How Are Trends Transforming The Genomic Cancer Panel And Profiling Market Landscape?
Major companies operating within the genomic cancer panel and profiling market are prioritizing technological improvements, such as next-generation sequencers, to enhance the precision, rapidity, and thoroughness of cancer diagnostics, enabling more individualized treatment choices. Next-generation sequencers are advanced DNA sequencing technologies that facilitate swift, high-throughput examination of genetic material to pinpoint mutations, variations, and other genomic attributes. For example, in April 2025, QIAGEN N.V., a biotechnology company based in the Netherlands, launched its QIAseq panels, which are designed for next-generation sequencers and permit comprehensive genomic profiling by analyzing over 700 genes. These panels are intended for both research and clinical applications, with the goal of improving cancer diagnostics and treatment approaches.
Who Are The Prominent Organizations Shaping The Genomic Cancer Panel And Profiling Market?
Major companies operating in the genomic cancer panel and profiling market are Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, ARUP Laboratories, Tempus Labs, Genscript Biotech Corporation, NeoGenomics Inc., Foundation Medicine, Invitae Corporation, Guardant Health Inc., Caris Life Sciences, Fulgent Genetics, NanoString Technologies Inc., Genecast Biotechnology Co. Ltd, Burning Rock DX, HTG Molecular Diagnostics Inc., Predictive Oncology Inc.
Read the full genomic cancer panel and profiling market report here:
Which Region Is Forecast To Lead The Genomic Cancer Panel And Profiling Market In Terms Of Market Size?
North America was the largest region in the genomic cancer panel and profiling market in 2025. The regions covered in the genomic cancer panel and profiling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Genomic Cancer Panel And Profiling Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=24225&type=smp
Browse Through More Reports Similar to the Global Genomic Cancer Panel And Profiling Market 2026, By The Business Research Company
Cancer Profiling Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-profiling-global-market-report
Genomics In Cancer Care Market Report 2026
https://www.thebusinessresearchcompany.com/report/genomics-in-cancer-care-global-market-report
Cancer Tumor Profiling Market Report 2026
https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model